About Microtest Diagnostics
Microtest Diagnostics was a Healthcare company based in London (United Kingdom) founded in 2002. It operates as a functions as an automated allergy testing service. It operates on a B2B model. Microtest Diagnostics has raised $2.5 million across 2 funding rounds from investors including European Union and Anglo Scientific. The company has 6 employees. The company is recorded as dissolved. Its focus areas include Diagnostics, Allergy Testing and Automated Systems. Its legal entity is MICROTEST MATRICES LIMITED. Its competitors include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Immunovent and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
Microtest Diagnostics, established in 2002 and currently in Dissolved stage, focuses on providing healthcare solutions, offering diagnostic solutions, allergy testing, and automated systems. Functions as an automated allergy testing service. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters London, United Kingdom
- Employees 6
- SectorsHealthcare
- Website microtestdx.com
- Legal Name Microtest Matrices Limited
- Total Equity Funding$2.5M (USD)
in 2 rounds
- InvestorsEuropean Union
& 1 more
- Employee Count6
Funding Insights of Microtest Diagnostics
Microtest Diagnostics has successfully raised a total of $2.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.5M
- Total Rounds 2
- First Round $2.5M
(Jun 2013)
- Investors Count 2
All 2 funding rounds of Microtest Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | – | Grant | – | – | |
| Jun 2013 | $2.5M | Series A | – | Anglo Scientific | – |
2 investors in total: 2 institutional.
Investors in Microtest Diagnostics
Microtest Diagnostics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Anglo Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Offers management and back office services to high-tech start-ups focused on AI. | 2001 | angloscientific.com | London, United Kingdom |
Investor details for Microtest Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Microtest Diagnostics
3 dated milestones of Microtest Diagnostics across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Microtest Diagnostics is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Grant,.
Competitors of Microtest Diagnostics
Microtest Diagnostics has 8 listed competitors in our database, 2 of them funded. They include Allergy Amulet, YorkTest, ATANIS Biotech, DST and Immunovent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| yorktest.com | 1982 | York, United Kingdom | $12.03M | 38 | At-home food and allergy test kits are developed by YorkTest. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. | |
| macroarraydx.com.ua | 2016 | Kiev, Ukraine | – | – | Allergen analyzers are provided for in-vitro IgE level determination. | |
| allergenis.com | 2017 | Hatfield, United States | – | – | Develops accurate allergy testing solutions for healthcare providers and patients. | |
| bangqibio.tcc.mode | 2020 | Suzhou, China | – | – | Instruments and reagents for immune disorder diagnosis are developed. |
Detailed competitors of Microtest Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as Microtest Diagnostics (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Microtest Diagnostics
Microtest Diagnostics was founded in 2002 and raised its 1st funding round 11 years after it was founded.
Microtest Diagnostics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Microtest Diagnostics is a funded company, having raised a total of $2.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Jun 2013.
Microtest Diagnostics has 6 employees.
Microtest Diagnostics, established in 2002 and currently in Dissolved stage, focuses on providing healthcare solutions, offering diagnostic solutions, allergy testing, and automated systems. Functions as an automated allergy testing service. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Microtest Diagnostics's top competitors include Allergy Amulet, ATANIS Biotech and YorkTest.
Microtest Diagnostics has 2 investors. Key investors include European Union, and Anglo Scientific.
Microtest Diagnostics operates through Microtest Matrices Limited.